|
|
You are searching for "CFAMM00135319" in compound. Total 1 results found.
Click on CFAM IDs and names to search or view in CFAM, click on external IDs to view the entity in its source database.
CFAM Mol ID | CFAMM00135319 |
Family | CFFCD122 Neuromedin-K receptor Ligand Osanetant Family |
Superfamily | CFSCD111 Neuromedin-K receptor Ligand Osanetant Superfamily |
Class | CFCCD95 Class 908 |
External ID | CHEMBL56835 |
External Source | CHEMBL |
PubChem CID |
9850582 |
Functional Category |
Bioactive |
Molecule Name |
SureCN676170 |
IUPAC Name |
N-[4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide |
Synonyms |
AGN-PC-0509FA;CHEBI:189995;KB-57369;L001433;159125-41-4;Benzamide,N-[4-[4-(acetylamino)-4-phenyl-1-piperidinyl]-2-(3,4-dichlorophenyl)butyl]-N-methyl-;N-[(2S)-4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-2,3,4,5,6-pentadeuterio-N-methylbenzamide;N-[(2S)-4-[4-(acetylamino)-4-phenylpiperidin-1-yl]-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide |
InChi |
InChI=1S/C31H35Cl2N3O2/c1-23(37)34-31(27-11-7-4-8-12-27)16-19-36(20-17-31)18-15-26(25-13-14-28(32)29(33)21-25)22-35(2)30(38)24-9-5-3-6-10-24/h3-14,21,26H,15-20,22H2,1-2H3,(H,34,37) |
InChiKey |
PGKXDIMONUAMFR-UHFFFAOYSA-N |
Formula | C31H35Cl2N3O2 |
Molecular Weight | 552.53 |
Cross Link | CHEMBL56835 |
Structure |
|
Statistics of CFAM Database |
CFAM currently contains 490,279 molecules in 87,136 families, 34,880 superfamilies and 11,643 classes. |
How to cite our database |
C. Zhang, L. Tao, C. Qin, P. Zhang, S.Y. Chen, X. Zeng, F. Xu, Z. Chen, S.Y. Yang and Y.Z. CFam: A Chemical Families Database Based on Iterative Selection of Functional Seeds and Seed-Directed Compound Clustering.
Nucl. Acids Res. 43 (D1): D558-D565 (2015) (First published online: November 20, 2014).
|
Last update by |
2014.08.29
|
48709 visits since 2014 .........
Dr.
Chen Yuzong
Deputy
Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|